Many spiropyrrolidinyl-oxindolyl analogues have been isolated from natural sources and identified as promising bioactive agents, e.g. spirotryprostatine A and spirotryprostatine B were found to be inhibitors of mammalian cell cycle at supplementary materials sup-8 Acta Cryst.
In the title molecule, C 27 H 24 N 2 O 2 , the pyrrolidin-2-one ring is almost planar (r.m.s. deviation = 0.003 Å ), the pyrrolidine ring has an envelope conformation (the N atom is the flap atom) and the cyclopentanone ring is twisted about the C q -C m bond (q = quaternary and m = methylene). The ketone O atoms are directed to opposite sides of the molecule. Supramolecular chains along the a axis are formed in the crystal packing mediated by N-HÁ Á ÁN and C-HÁ Á ÁO interactions. These are connected into layers in the ab plane via C-HÁ Á Á interactions.
Related literature
For the biological activity of spiropyrrolidinyl-oxindolyl analogues, see: James & Williams (1972) ; Cui et al. (1996a,b) ; Palmisano et al. (1996); Garcia Prado et al. (2007) ; Girgis (2009b) ; Girgis et al. (2012) . For related structures, see: Moustafa et al. (2008) ; Li et al. (2008) . For the synthesis, see: Girgis et al. (2009a) . For conformational analysis, see: Cremer & Pople (1975) .
Experimental
Crystal data C 27 H 24 N 2 O 2 M r = 408.48 Triclinic, P1 a = 6.2414 (2) Å b = 11.3954 (5) Å c = 15.5563 (7) Å = 78.386 (2) = 87.165 (2) = 77.046 (2) V = 1056.17 (7) Å 3 Z = 2 Mo K radiation = 0.08 mm À1 T = 293 K 0.25 Â 0.08 Â 0.05 mm
Data collection
Nonius KappaCCD diffractometer Absorption correction: multi-scan (SORTAV; Blessing 1995) T min = 0.852, T max = 0.991 12225 measured reflections 4833 independent reflections 2335 reflections with I > 2(I) R int = 0.081 Refinement R[F 2 > 2(F 2 )] = 0.062 wR(F 2 ) = 0.154 S = 1.01 4833 reflections 285 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Á max = 0.21 e Å À3 Á min = À0.23 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Cg1 and Cg2 are the centroids of the C13-C18 and C21-C26 rings, respectively. Data collection: COLLECT (Hooft, 1998) ; cell refinement: SCALEPACK (Otwinowski & Minor, 1997) ; data reduction: DENZO and SCALEPACK; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010) .
We thank the Ministry of Higher Education (Malaysia) for funding structural studies through the High-Impact Research scheme (UM.C/HIR/MOHE/SC/12). G2/M phase, from the secondary metabolites of Aspergillus fugimatus (Cui et al., 1996a; Cui et al., 1996b) . Elacomine (James & Williams, 1972) was isolated from Eleagnus commutata, and horsfiline (Palmisano et al., 1996) , from Horsfieldia superba, a small Malaysian tree, extracts of which have found use in indigenous medicine. Mitraphylline was isolated from Uncaria tomentosa (cat's claw) and identified as an anti-tumour agent against human brain cancer cell lines, neuroblastoma SKN-BE(2) and malignant glioma GAMG (Garcia Prado et al., 2007) . One of the driving forces for initiating this work was our previous observations that compounds with alkaloid heterocyclic system skeletons, such as
piperidine]-2(1H),4′′-diones, revealed promising anti-tumour properties against SK-MEL-2 (melanoma) cell line (Girgis, 2009a) , and colon (HCT-116), breast (T-47D), leukemia [HL-60 (TB), MOLT-4, RPMI-8226] and prostate (PC-3) cell line cancers (Girgis, 2009b) . Additionally, the analogue reported herein revealed mild anti-tumour properties against HCT116 (colon), HELA (cervical), HEPG2 (liver) and MCF7 (breast) human tumor cell lines (IC 50 values = 33.81, 41.10, 23.89, 42.23 µM, respectively), compared to that of the standard drug Doxorubicin (IC 50 = 6. 86, 7.71, 7.36, 5.46 µM, respectively) , utilizing the standard Sulfo-Rhodamine-B (SRB) method (Girgis et al., 2012) . With this background in mind, and in continuation of related structure studies (Moustafa et al., 2008) , herein we describe the crystal and molecular structure of the title compound, 2,
In (I), Fig. 1 , the pyrrolidin-2-one ring is planar (r.m.s. deviation = 0.003 Å), the pyrrolidine ring has an envelope conformation where the N2 atom is the flap atom, and the cyclopentanone ring is twisted about the C11-C27 bond (Cremer & Pople, 1975) . The ketone-O atoms are directed to opposite sides of the molecule. The overall conformation of the (I) matches that of the isoindole-1,3-dione derivative (Li et al., 2008) with the greatest difference being found in the dihedral angle between the 2,3-dihydroisoindol-1-one and tolyl ring in (I), i.e. 23.97 (11)°, compared to 48.63 (7)° for the dihedral angle between the isoindole-1,3-dione and tolyl rings in the literature structure.
In the crystal packing, supramolecular chains along the a axis are formed by N-H···N hydrogen bonds complemented by C-H···O interactions with both carbonyl-O atoms participating in these contacts, Fig. 2 
Experimental
The compound was prepared in accord with the literature procedure (Girgis et al., 2009a) . A mixture of 2(E)-2,3-dihydro-2-[(4-methylphenyl)methylene]-1H-inden-1-one 1 (1.17 g, 5 mmol), isatin 2 (0.81 g, 5.5 mmol) and sarcosine 3 (0.49 g, 5.5 mmol) in absolute ethanol (25 ml) was boiled under reflux. The separated solid was collected and recrystallized from n-butanol by slow evaporation affording the title compound as colourless crystals, M.pt. 481-483 K.
Yield: 80%.
Refinement
Carbon-bound H-atoms were placed in calculated positions [C-H = 0.93 to 0.98 Å, U iso (H) = 1.2-1.5U eq (C)] and were included in the refinement in the riding model approximation. The N-bound H atom was refined with N-H = 0.86±0.01 Å, and with U iso (H) = 1.2U eq (N).
Computing details
Data collection: COLLECT (Hooft, 1998) ; cell refinement: SCALEPACK (Otwinowski & Minor, 1997) ; data reduction:
DENZO and SCALEPACK (Otwinowski & Minor, 1997) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010) . Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq O1 0.6791 (2) 0.04076 (16) 
